Position in FTH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$36,100,975
New position
Shares Held
1,444,039
first reported quarter
Ownership
5.59%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#2
of 45 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Avoro Capital Advisors LLC holds $9,631,167,263 across 25 Biotechnology names. FTH ranks #23 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
5,111,111 | $1,363,235,525 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
2,888,888 | $1,073,713,002 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,833,333 | $984,408,154 | |
| 4 | ARGX |
Argenx SE
|
1,000,000 | $927,770,000 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
11,355,555 | $925,591,288 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
7,474,747 | $857,129,238 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,297,000 | $430,182,160 | |
| 8 | CYTK |
Cytokinetics Inc
|
4,999,999 | $425,949,914 |
All Filings in FTH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,100,975 | 1,444,039 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||